Cerebrospinal Fluid Cytokines and Neurodegeneration-Associated Proteins in Parkinson's Disease.
dc.contributor.author | Wijeyekoon, Ruwani S | |
dc.contributor.author | Moore, Sarah F | |
dc.contributor.author | Farrell, Krista | |
dc.contributor.author | Breen, David P | |
dc.contributor.author | Barker, Roger A | |
dc.contributor.author | Williams-Gray, Caroline H | |
dc.date.accessioned | 2020-02-20T00:30:40Z | |
dc.date.available | 2020-02-20T00:30:40Z | |
dc.date.issued | 2020-06 | |
dc.identifier.issn | 0885-3185 | |
dc.identifier.uri | https://www.repository.cam.ac.uk/handle/1810/302418 | |
dc.description.abstract | INTRODUCTION: Immune markers are altered in Parkinson's disease (PD), but relationships between cerebrospinal fluid (CSF) and plasma cytokines and associations with neurodegeneration-associated proteins remain unclear. METHODS: CSF and plasma samples and demographic/clinical measures were obtained from 35 PD patients. CSF samples were analyzed for cytokines (together with plasma) and for α-synuclein, amyloid β(1-42) peptide, total tau, and phospho(Thr231)-tau. RESULTS: There were no CSF-plasma cytokine correlations. Interleukin (IL)-8 was higher and interferon-γ, IL-10, and tumor necrosis factor-α were lower in CSF versus plasma. In CSF, total tau correlated positively with IL-8 and IL-1β, whereas α-synuclein correlated positively with amyloid β(1-42) and negatively with semantic fluency (a known marker of PD dementia risk). DISCUSSION: CSF and peripheral cytokine profiles in PD are not closely related. Associations between CSF IL-8 and IL-1β and tau suggest that CSF inflammatory changes may relate to tau pathology within PD. CSF α-synuclein/amyloid β may reflect the risk of developing PD dementia. © 2020 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society. | |
dc.description.sponsorship | Funding for this work was provided by the Rosetrees Trust (M369-F1), Addenbrooke’s Charitable Trust (PF15/CWG) and the NIHR Cambridge Biomedical Research Centre Dementia and Neurodegeneration Theme (146281). RSW was supported by a Fellowship from Addenbrooke’s Charitable Trust (RG77199). SFM was supported by the Transeuro EU FP7 grant (242003) and is now an NIHR Academic Clinical Fellow (ACF-2015-23-501). DPB is supported by a Wellcome Trust Clinical Research Career Development Fellowship. RAB is an NIHR Senior Investigator (NF-SI-0616-10011) and is supported by the Wellcome Trust-MRC Cambridge Stem Cell Institute. CHWG holds a RCUK/UKRI Research Innovation Fellowship awarded by the Medical Research Council (MR/R007446/1) and receives support from the Cambridge Centre for Parkinson-Plus. | |
dc.format.medium | Print-Electronic | |
dc.language | eng | |
dc.publisher | Wiley | |
dc.rights | All rights reserved | |
dc.subject | Humans | |
dc.subject | Parkinson Disease | |
dc.subject | Peptide Fragments | |
dc.subject | tau Proteins | |
dc.subject | Cytokines | |
dc.subject | alpha-Synuclein | |
dc.subject | Amyloid beta-Peptides | |
dc.subject | Biomarkers | |
dc.title | Cerebrospinal Fluid Cytokines and Neurodegeneration-Associated Proteins in Parkinson's Disease. | |
dc.type | Article | |
prism.endingPage | 1066 | |
prism.issueIdentifier | 6 | |
prism.publicationDate | 2020 | |
prism.publicationName | Mov Disord | |
prism.startingPage | 1062 | |
prism.volume | 35 | |
dc.identifier.doi | 10.17863/CAM.49489 | |
dcterms.dateAccepted | 2020-02-13 | |
rioxxterms.versionofrecord | 10.1002/mds.28015 | |
rioxxterms.version | AM | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2020-06 | |
dc.contributor.orcid | Barker, Roger [0000-0001-8843-7730] | |
dc.contributor.orcid | Williams-Gray, Caroline [0000-0002-2648-9743] | |
dc.identifier.eissn | 1531-8257 | |
rioxxterms.type | Journal Article/Review | |
pubs.funder-project-id | Addenbrooke's Charitable Trust (ACT) (9968 MINUTE NO 24/14B) | |
pubs.funder-project-id | Addenbrooke's Charitable Trust (ACT) (PF15/CWG) | |
pubs.funder-project-id | Cambridge University Hospitals NHS Foundation Trust (CUH) (146281) | |
pubs.funder-project-id | Medical Research Council (MR/R007446/1) | |
pubs.funder-project-id | Medical Research Council (MC_PC_12009) | |
pubs.funder-project-id | Medical Research Council (MC_PC_17230) | |
pubs.funder-project-id | European Commission (242003) | |
pubs.funder-project-id | Wellcome Trust (203151/Z/16/Z) | |
cam.issuedOnline | 2020-03-04 | |
cam.orpheus.success | Tue Mar 31 10:35:51 BST 2020 - Embargo updated | |
rioxxterms.freetoread.startdate | 2023-02-19 |
Files in this item
This item appears in the following Collection(s)
-
Cambridge University Research Outputs
Research outputs of the University of Cambridge